Investor presentation
Logotype for Lakeland Industries Inc

Lakeland Industries (LAKE) Investor presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Lakeland Industries Inc

Investor presentation summary

8 May, 2026

Corporate overview and strategy

  • Manufactures a comprehensive range of personal protective equipment, including firefighter gear, chemical suits, and high-visibility clothing, with a global footprint spanning nine manufacturing locations in eight countries and sales in over 50 countries.

  • Recent acquisitions include Arizona PPE Recon, California PPE Recon, Veridian Limited, LHD Group, Jolly Scarpe, and Pacific Helmets, enhancing product offerings and geographic reach.

  • Focuses on high-growth markets, expanding decontamination and rental services, and leveraging cross-selling opportunities from a head-to-toe product portfolio.

  • Holds 42 patents and 51 trademarks, supporting a strong competitive position with fast delivery lead times and a robust acquisition pipeline.

  • Strategic priorities include building a premier global fire brand, expanding through M&A, and driving operating leverage via cross-selling and operational optimization.

Product and service portfolio

  • Offers NFPA- and CE-certified fire turnout gear, safety helmets, fire boots, gloves, chemical suits, disposable coveralls, and FR/AR wear.

  • Provides decontamination, repair, and rental services, creating recurring revenue streams and sticky customer relationships.

  • Serves professional and volunteer fire departments, industrial, energy, utilities, healthcare, and clean room sectors.

  • Recent product launches include the FireFlex Elite L-100 Structural Firefighting Boot.

Financial performance and highlights

  • FY26 net sales grew 15.2% to $192.6M, driven by 48.6% growth in the fire services portfolio.

  • Adjusted gross margin declined to 34.4% from 42.5% year-over-year; adjusted EBITDA excluding FX was $7.2M, down from $17.4M.

  • Net loss widened to $25.3M from $18.1M in the prior year.

  • Cash and cash equivalents at year-end were $12.5M, not including $14M from the divestiture of the HPFR/HiViz product line.

  • Inventory reduction initiatives led to a $5.4M decrease quarter-over-quarter, with inventory flat year-over-year despite 15% sales growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more